Wacker has announced plans to invest $30 million to expand its facility in Jena, Germany. The expansion will cover the GMP production facility as well as the construction of a new building for process development and quality control. “The new facilities will enable us to greatly accelerate our growth in the attractive biologics market,” states Dr. Gerhard Schmid, president of Wacker Fine Chemicals, the Group’s biotech and fine chemicals division. The investment involves ...